Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Conventional Antipsychotics for Acute Mania in Sweden
NCT00767715Phase 4Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olanzapine in bipolar I disorder, sponsored by Eli Lilly and Company. Started Oct 2004; status: terminated.
02
Drugs
olanzapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00767715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767715.